Skip to main content
Immune Tolerance Network
Developing, funding and conducting clinical trials in immune tolerance
Share This
Home

ALLTOL is a Clinical Study to Learn More about Tolerance in Organ Transplantation

 

ALLTOL is no longer enrolling study participants

  • Home
  • Transplantation & Tolerance
  • About ALLTOL
  • Am I Eligible?
  • Study Locations

A Study of Kidney and Liver Transplant Recipients

ALLTOL is a clinical study to learn more about tolerance in organ transplantation.

Study Details:

This study is observational, meaning there are no study medications or procedures. 

This study will last for up to five years, and will require 1 study visit per year. These visits will include:

  • Overall health assessment
  • Blood and urine collections

If you cannot travel to a study site, the study site staff will discuss your health status by phone and arrange for a nurse to come to your location to collect the research specimens.

The study will run until January 31, 2021.  Study participation will last for the amount of time left in the study at the time of enrollment (up to 5 years).

Find out if you are eligible to participate in ALLTOL. 

  • About ITN
  • More ITN Trials

Resources

  • Children & Clinical Studies
  • Patient Rights & Informed Consent
  • Understanding Clinical Trials
 

ALLTOL is being conducted by the Immune Tolerance Network and is sponsored by the National Institute of Allergy and Infectious Diseases (NIH funded). 

  • Home
  • About DISEASE
  • About ALLTOL
  • Am I Eligible?
  • Study Locations
  • About ITN
  • More ITN Trials
  • Children & Clinical Studies
  • Patient Rights & Informed Consent
  • Understanding Clinical Trials